ctrl K

Watchlist Price Alert

Eupraxia Pharmaceuticals ... (EPRX)

NASDAQ: EPRX · Real-Time Price · USD

3.87

0.11 (2.93%)

At close: May 13, 2025, 3:20 PM

3.75

-3.10%

After-hours: May 13, 2025, 05:40 PM EDT

Eupraxia Pharmaceuticals Income Statement

Financials in CAD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	209.91K	193.27K	111.53K	116.81K	201.94K	125.83K	85.38K
Gross Profit	-209.91K	-193.27K	-111.53K	-116.81K	-201.94K	-125.83K	-85.38K
Operating Income	-37.2M	-22.63M	-20.87M	-2.25M	-6.15M	-14.31M	-4.97M
Interest Income	407.04K	569.32K	65.73K	427.00	12.04K	1.11K	330.00
Pretax Income	-38.33M	-23.92M	-23.37M	-4.01M	-7.24M	-14.83M	-5M
Net Income	-37.39M	-23.26M	-22.99M	-4M	-7.18M	-13.23M	-4.32M
Selling & General & Admin	9.65M	5.81M	8.89M	1.27M	3.01M	7.54M	1.7M
Research & Development	27.54M	17.2M	9.68M	859.78K	2.94M	6.64M	3.19M
Other Expenses	0.00	n/a	-2.26M	n/a	1.74K	n/a	n/a
Operating Expenses	37.2M	23.2M	18.68M	2.25M	6.16M	14.31M	4.97M
Interest Expense	821.66K	1.59M	1.3M	1.88M	1.46M	142.17K	52.81K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	37.2M	23.2M	18.68M	2.25M	6.16M	14.31M	4.97M
Income Tax Expense	48.26K	930.52K	-1.34M	1.87M	1.4M	-1.46M	-627.56K
Shares Outstanding (Basic)	24.15M	19.29M	14.24M	12.87M	12.87M	12.87M	12.87M
Shares Outstanding (Diluted)	24.15M	19.29M	14.24M	12.87M	12.87M	12.87M	12.87M
EPS (Basic)	-1.58	-1.21	-1.61	-0.31	-0.56	-1.03	-0.34
EPS (Diluted)	-1.58	-1.21	-1.61	-0.31	-0.56	-1.03	-0.34
EBITDA	-36.75M	-22.14M	-21.96M	-2.01M	-5.94M	-14.57M	-4.89M
EBIT	-36.9M	-22.33M	-22.07M	-2.13M	-5.78M	-14.69M	-4.95M
Depreciation & Amortization	149.57K	193.27K	111.53K	116.81K	201.94K	125.83K	85.38K